Vera Therapeutics announces $250M public offering of 8.1M shares at $31.00 per share

Vera Therapeutics, Inc.

Offering of 8,064,517 shares of Class A common stock at $31.00/share; gross proceeds ~$250.0M.
Underwriters granted 30-day option to purchase up to 1,209,677 additional shares at same price less discounts.
Underwriters include J.P. Morgan, Cowen, and Evercore as representatives; closing expected Feb 1, 2024.
Use of proceeds not specified in the filing; likely general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.